Nazara Technologies Capital Structure Change

Nazara Technologies Earnings Call Transcript: Key Takeaways

Nazara reported record Q2 revenue driven by the strategic consolidation of BlueTriton and Bestplay. Management is pivoting toward an AI-led 'Global Gaming Platform' model to drive efficiency.

Nazara Technologies Investor Presentation: Key Takeaways

Q2FY27 consolidated revenue INR 803 Cr (+53%), EBITDA INR 120 Cr (+93%), margin 14.9%. Bluetile consolidated from 1-Aug-26.

Nazara Technologies Results Update

Nazara Technologies reported record Q2FY27 revenue of INR 803 crore, up 53%, and EBITDA of INR 120 crore, up 93%. The press release also covers the first quarter with Bluetile and BestPlay consolidated.

Nazara Technologies Q2 FY27 Results: Turns Profitable, Net Profit ₹35.4 Cr

Nazara Technologies Ltd reported revenue from operations of ₹803.1 Cr (+52.5% YoY) and net profit of ₹35.4 Cr for Q2 FY27.

Key figure

Net profit ₹35.4 Cr

Nazara Technologies Preferential Issue

Nazara Technologies approved the preferential allotment of 2.39 crore equity shares for Rs. 730.78 Crore. This capital raise was issued to strategic investors.

Value

₹730.8 Cr

Nazara Technologies Other Announcement

Nazara Technologies Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory filing.

Sona BLW Precision Forgings Capital Structure Change

ICICI Prudential Mutual Fund disclosed an open-market sale of about 122.99 million Sona BLW shares. Its stake fell from 7.06% to 5.05% over the relevant period.

DCM Shriram Industries Capital Structure Change

Mugi Constructions and two PACs bought 45,94,000 DCM Shriram shares in the open market, reaching 5.281% of equity. The cross-5% Reg 29(1) disclosure signals a non-promoter accumulation.

MRC Agrotech Capital Structure Change

Wordexx Ventures Pvt Ltd, a non-promoter, sold 5,84,823 MRC Agrotech shares in open market, reducing its stake from 10.62% to 8.75%. No transaction value disclosed.

Natco Pharma Capital Structure Change

Natco Pharma allotted 5,86,666 equity shares to promoter Venkaiah Chowdary Nannapaneni via its rights issue, valued at ~₹44 Crore. This lifts his stake to 14.60%.

Value

₹44.00 Cr

RGF Capital Markets Capital Structure Change

Nishad J. Shah and PACs acquired 2,54,80,900 RGF Capital Markets shares (16.98%) off-market via SPA. The non-promoter buy will trigger an open offer before promoter classification.

Suvidhaa Infoserve Capital Structure Change

Suvidhaa Infoserve Ltd approved the terms for its Rights Issue, including a price of ₹1.50 per share. The issue size is ₹11.80 Crore.

Value

₹11.80 Cr